Ear seeds: a Needle-Free hope against childhood nearsightedness?

NCT ID NCT07746804

First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time

Summary

This trial tests whether auricular acupressure—small adhesive patches with seeds placed on specific ear points—can prevent myopia in children who are at higher risk. Primary school students in grades 1-4 with insufficient hyperopic reserve (a sign they may become nearsighted) will be randomly assigned to receive weekly ear acupressure or continue their usual activities. Over 12 months, researchers will measure changes in eye length and refractive error, and track how many children develop myopia, to see if this simple intervention makes a difference.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Auricular acupressure using adhesive patches with vaccaria seeds applied to specific ear points
What this could lead to
If effective, this simple, non-invasive ear acupressure could offer a drug-free way to slow myopia progression in children, potentially reducing the global burden of nearsightedness.
What could go wrong
This is a small, early-stage trial, and the effect may be modest or no better than usual activities. Adherence to pressing the patches is key, and results may not generalize beyond this specific age group.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPEROPIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Shanghai Eye Disease Prevention and Treatment Center

    RECRUITING

    Shanghai, Shanghai Municipality, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.